Brent Jason Benscoter, MD
Otolaryngology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 19 years
- University of Missouri, Columbia School of Medicine, 2007
Offices
2 locations · Sacramento Ear Nose and Throat Surgical and Medical Group Inc · Marshall Medical Center
Hospitals listed: Mercy General Hospital · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Benscoter’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A150679 · Current
Licensed to practise in California · since 2017 · expires 2027-07-31 · University of Missouri-Columbia School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 125053418Temporary Medical Permit · since 2010 · expires 2012-06-30Specialty on the licence: OtolaryngologyExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Otolaryngology - Neurotology
- American Board of Otolaryngology - Otolaryngology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy General HospitalSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.43 (1.15 to 1.7), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.85 (2.2 to 3.51) · 4,531 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.124, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.18, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy General Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.43 (1.15 to 1.7) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.85 (2.2 to 3.51) · 4,531 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.124 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.18 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.82 (0 to 1.78) · 1,035 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.19 (116.89 to 215.48) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 142 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.2 · 431 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.8 · 348 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 242 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,346 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 5,509 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.06 to 0.45) · 6,091 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (1.01 to 4.84) · 1,995 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.42 (0.01 to 2.83) · 863 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.86 (0.49 to 3.22) · 1,834 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.67 (1.97 to 11.37) · 927 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.8 (0 to 5.97) · 914 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.06) · 331 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 171 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.457 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.426 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.306 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 902 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 642 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.6 · 513 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 23.5 · 445 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.5 · 229 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 349 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 168 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 295 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 175 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.3 to 16.4) · 405 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 516 cases | No different | Jan 2024 – Dec 2024 |
What patients said (477 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$186,768
Medicare paid this office $186,768 for 333 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of cochlear device | 23 | $21,792 | $947 |
| New patient visit (60+ min) | 76 | $13,491 | $178 |
| Creation of flap graft to head and/or neck | 29 | $11,805 | $407 |
| Creation of skin, fat and muscle graft | 40 | $11,007 | $268 |
| Return visit (30+ min) | 90 | $10,185 | $93 |
See all 24 services
| Insertion of cochlear device | 23 | $21,792 | $947 |
| New patient visit (60+ min) | 76 | $13,491 | $178 |
| Creation of flap graft to head and/or neck | 29 | $11,805 | $407 |
| Creation of skin, fat and muscle graft | 40 | $11,007 | $268 |
| Return visit (30+ min) | 90 | $10,185 | $93 |
| Exam of ear using a microscope | 266 | $9,243 | $24 |
| Reconstruction of ear canal | 16 | $8,993 | $562 |
| Repair of opening to cochlea | 23 | $7,552 | $328 |
| Long return visit (40+ min) | 46 | $7,080 | $136 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 39 | $7,036 | $71 |
| Short return visit (20+ min) | 76 | $6,309 | $64 |
| New patient visit (45+ min) | 47 | $5,714 | $122 |
| Ct scan of cranial cavity without contrast | 42 | $5,396 | $123 |
| Comprehensive hearing and speech recognition test | 166 | $5,293 | $28 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 37 | $3,617 | $63 |
| New patient visit (30+ min) | 32 | $2,767 | $86 |
| Analysis and programming of inner ear implant (7 years or older) | 18 | $2,037 | $113 |
| Removal of impacted ear wax | 25 | $1,404 | $39 |
| Exam of the nose and throat using an endoscope | 13 | $1,344 | $103 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 24 | $1,018 | $42 |
| Simple removal of skin debris and drainage of mastoid cavity | 14 | $997 | $59 |
| Test to assess middle ear function | 65 | $898 | $13 |
| Test for hearing various pitches using earphone and device placed against the bone | 18 | $661 | $37 |
| Test for eardrum and muscle function | 12 | $205 | $17 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Creation of skin, fat and muscle graft | 28 | 41 | 49 | 40 | 51 | 41 |
| Removal of impacted ear wax | 29 | 19 | 16 | 13 | – | 36 |
| Creation of flap graft to head and/or neck | – | – | 17 | 16 | 30 | 29 |
| Reconstruction of ear canal | 14 | 13 | 28 | 14 | – | 16 |
| Repair of opening to cochlea | 11 | 14 | – | – | 27 | 23 |
| Simple removal of skin debris and drainage of mastoid cavity | 23 | – | – | 20 | 15 | 17 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
333 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 14% · Women 53% · Also on Medicaid 22% · Health risk score 1.10. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 68% · Diabetes 29% · Coronary heart disease 22% · Chronic kidney disease 19% · Depression 19% · Atrial fibrillation 14% · COPD 13% · Cancer 11% · Heart failure 10% · Stroke 8% · Dementia 4%.
The office billed $947,600, Medicare allowed $244,959 and paid $186,768; for 1,748 services of 68 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 333 | 1,748 | 74 | 1.10 | $947,600 | $186,768 |
| 2023 | 341 | 2,107 | 73 | 0.99 | $1,028,604 | $217,060 |
| 2022 | 305 | 1,776 | 73 | 1.13 | $814,966 | $162,255 |
| 2021 | 326 | 1,847 | 73 | 1.04 | $921,900 | $194,110 |
| 2020 | 279 | 1,602 | 72 | 1.09 | $769,381 | $153,618 |
| 2019 | 286 | 1,425 | 73 | 1.18 | $694,107 | $136,283 |
| 2018 | 247 | 1,242 | 72 | 1.06 | $635,898 | $123,320 |
| 2017 | 762 | 1,705 | 77 | 1.05 | $245,880 | $97,400 |
| 2016 | 736 | 1,713 | 76 | 0.99 | $264,447 | $108,781 |
| 2015 | 657 | 1,837 | 76 | 1.05 | $239,911 | $102,869 |
| 2014 | 317 | 972 | 75 | 0.96 | $117,250 | $53,190 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Insertion of cochlear device | 25 | $24,850 | $994 |
| Creation of skin, fat and muscle graft | 48 | $14,205 | $279 |
| Creation of flap graft to head and/or neck | 30 | $13,570 | $452 |
| New patient visit (60+ min) | 74 | $13,187 | $178 |
| Exam of ear using a microscope | 304 | $11,997 | $24 |
| Return visit (30+ min) | 88 | $10,043 | $93 |
| Ct scan of cranial cavity without contrast | 65 | $9,922 | $134 |
| Repair of opening to cochlea | 27 | $9,293 | $344 |
| Long return visit (40+ min) | 54 | $8,950 | $144 |
| Short return visit (20+ min) | 91 | $8,776 | $68 |
| New patient visit (45+ min) | 68 | $8,400 | $124 |
| Comprehensive hearing and speech recognition test | 186 | $6,170 | $29 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 35 | $5,982 | $72 |
| Incision of fluid canal of inner ear with infusion of drugs | 11 | $5,520 | $197 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 39 | $3,760 | $68 |
| New patient visit (30+ min) | 34 | $2,967 | $87 |
| Analysis and programming of inner ear implant (7 years or older) | 18 | $2,306 | $128 |
| Simple removal of skin debris and drainage of mastoid cavity | 13 | $966 | $64 |
| Test to assess middle ear function | 69 | $955 | $13 |
| Test for hearing various pitches using earphone and device placed against the bone | 15 | $503 | $34 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 12 | $489 | $41 |
| Test for eardrum and muscle function | 14 | $230 | $16 |
| Injection, dexamethasone sodium phosphate, 1 mg | 11 | $27 | None |
2022: 22 services
| New patient visit (45+ min) | 88 | $11,094 | $126 |
| Creation of skin, fat and muscle graft | 37 | $10,930 | $273 |
| Return visit (30+ min) | 93 | $10,294 | $92 |
| Exam of ear using a microscope | 261 | $10,122 | $24 |
| Short return visit (20+ min) | 93 | $9,477 | $67 |
| Ct scan of cranial cavity without contrast | 50 | $7,605 | $138 |
| Creation of flap graft to head and/or neck | 15 | $7,232 | $452 |
| Reconstruction of ear canal | 14 | $6,883 | $492 |
| Comprehensive hearing and speech recognition test | 170 | $5,689 | $30 |
| New patient visit (30+ min) | 42 | $3,753 | $89 |
| New patient visit (60+ min) | 21 | $3,117 | $148 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 20 | $3,102 | $70 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 22 | $2,397 | $68 |
| Test to assess middle ear function | 73 | $1,065 | $13 |
| Simple removal of skin debris and drainage of mastoid cavity | 18 | $1,013 | $51 |
| Test to assess balance during warm and cool irrigation in both ears | 16 | $524 | $31 |
| Removal of impacted ear wax | 12 | $436 | $34 |
| Test for abnormal eye movement using 3 positions with recording | 16 | $356 | $22 |
| Test for hearing various pitches using earphone and device placed against the bone | 11 | $319 | $29 |
| Test for abnormal eye movement with recording | 16 | $301 | $19 |
| Test for eardrum and muscle function | 16 | $294 | $17 |
| Test for abnormal eye movement using a moving target that moves back and forth with recording | 16 | $214 | $13 |
2021: 24 services
| New patient visit (45+ min) | 117 | $15,693 | $134 |
| Reconstruction of ear canal | 27 | $14,422 | $515 |
| Creation of skin, fat and muscle graft | 44 | $13,712 | $280 |
| Repair of eardrum and ear canal with removal of middle ear bone | 11 | $10,918 | $993 |
| Exam of ear using a microscope | 277 | $10,540 | $24 |
| Return visit (30+ min) | 76 | $10,399 | $101 |
| Short return visit (20+ min) | 94 | $8,624 | $64 |
| Ct scan of cranial cavity without contrast | 51 | $7,870 | $138 |
| Creation of flap graft to head and/or neck | 17 | $7,380 | $434 |
| Comprehensive hearing and speech recognition test | 164 | $5,375 | $31 |
| New patient visit (30+ min) | 52 | $3,898 | $75 |
| New patient visit (60+ min) | 18 | $3,137 | $174 |
| Analysis and reprogramming of inner ear implant (7 years or older) | 17 | $2,927 | $81 |
| Evaluation of hearing function related to surgically implanted hearing device, first hour | 29 | $2,472 | $71 |
| Long return visit (40+ min) | 15 | $2,445 | $153 |
| Test to assess middle ear function | 82 | $1,150 | $13 |
| Removal of impacted ear wax | 14 | $645 | $40 |
| Test to assess balance during warm and cool irrigation in both ears | 16 | $541 | $34 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $520 | $40 |
| Test for eardrum and muscle function | 20 | $419 | $19 |
| Test for hearing various pitches using earphone and device placed against the bone | 12 | $383 | $29 |
| Test for abnormal eye movement using 3 positions with recording | 16 | $379 | $24 |
| Test for abnormal eye movement with recording | 16 | $326 | $20 |
| Test for abnormal eye movement using a moving target that moves back and forth with recording | 16 | $217 | $14 |
2020: 21 services
| Insertion of cochlear device | 14 | $13,948 | $996 |
| New patient visit (45+ min) | 90 | $11,525 | $128 |
| Creation of skin, fat and muscle graft | 35 | $11,457 | $279 |
| Exam of ear using a microscope | 238 | $8,881 | $23 |
| Short return visit (20+ min) | 98 | $7,048 | $51 |
| Reconstruction of ear canal | 13 | $6,925 | $533 |
| Ct scan of cranial cavity without contrast | 37 | $5,664 | $145 |
| Return visit (30+ min) | 56 | $4,927 | $78 |
| Repair of opening to cochlea | 14 | $4,723 | $337 |
| New patient visit (30+ min) | 58 | $4,282 | $74 |
| Comprehensive hearing and speech recognition test | 135 | $4,210 | $29 |
| Long return visit (40+ min) | 14 | $2,173 | $121 |
| Test to assess middle ear function | 60 | $856 | $13 |
| Test to assess balance during warm and cool irrigation in both ears | 22 | $785 | $36 |
| Removal of impacted ear wax | 18 | $717 | $38 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 14 | $590 | $42 |
| Test for abnormal eye movement using 3 positions with recording | 22 | $555 | $25 |
| Test for abnormal eye movement with recording | 22 | $475 | $22 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $415 | $35 |
| Test for abnormal eye movement using a moving target that moves back and forth with recording | 22 | $308 | $14 |
| Test for eardrum and muscle function | 14 | $263 | $19 |
2019: 19 services
| New patient visit (45+ min) | 96 | $11,955 | $125 |
| Insertion of cochlear device | 11 | $10,326 | $939 |
| Exam of ear using a microscope | 235 | $9,675 | $24 |
| Ct scan of cranial cavity without contrast | 56 | $8,991 | $147 |
| Reconstruction of ear canal | 14 | $8,628 | $616 |
| Return visit (30+ min) | 78 | $8,600 | $86 |
| Creation of skin, fat and muscle graft | 28 | $7,463 | $267 |
| Short return visit (20+ min) | 99 | $7,393 | $52 |
| Comprehensive hearing and speech recognition test | 120 | $4,120 | $31 |
| New patient visit (30+ min) | 52 | $4,020 | $77 |
| Repair of opening to cochlea | 11 | $3,446 | $313 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 16 | $3,152 | $166 |
| Long return visit (40+ min) | 18 | $2,122 | $118 |
| Simple removal of skin debris and drainage of mastoid cavity | 12 | $1,248 | $54 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 27 | $1,015 | $38 |
| Removal of impacted ear wax | 26 | $990 | $34 |
| Test to assess middle ear function | 43 | $593 | $13 |
| Test for hearing various pitches using earphone and device placed against the bone | 12 | $393 | $33 |
| Test for eardrum and muscle function | 13 | $239 | $18 |
2018: 20 services
| Insertion of cochlear device | 12 | $11,559 | $963 |
| Creation of skin, fat and muscle graft | 40 | $10,426 | $254 |
| Reconstruction of ear canal | 15 | $8,289 | $553 |
| Exam of ear using a microscope | 192 | $8,193 | $24 |
| New patient visit (45+ min) | 64 | $7,770 | $121 |
| Return visit (30+ min) | 71 | $6,690 | $82 |
| Short return visit (20+ min) | 66 | $6,155 | $58 |
| New patient visit (30+ min) | 73 | $5,776 | $79 |
| Ct scan of cranial cavity without contrast | 23 | $3,559 | $148 |
| Comprehensive hearing and speech recognition test | 110 | $3,543 | $29 |
| Long return visit (40+ min) | 27 | $2,976 | $110 |
| Removal of impacted ear wax | 41 | $1,650 | $37 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 24 | $1,027 | $41 |
| Continuous monitoring of nervous system during operation, each 15 minutes | 31 | $808 | $25 |
| Test to assess middle ear function | 38 | $445 | $11 |
| Test to assess balance during warm and cool irrigation in both ears | 13 | $393 | $30 |
| Test for hearing various pitches using earphone and device placed against the bone | 11 | $352 | $32 |
| Test for abnormal eye movement using 3 positions with recording | 12 | $271 | $23 |
| Test for abnormal eye movement with recording | 12 | $238 | $20 |
| Test for abnormal eye movement using a moving target that moves back and forth with recording | 12 | $152 | $13 |
2017: 16 services
| Short return visit (20+ min) | 471 | $27,211 | $45 |
| New patient visit (45+ min) | 98 | $10,781 | $110 |
| New patient visit (30+ min) | 165 | $10,635 | $64 |
| Incision of fluid canal of inner ear with infusion of drugs | 13 | $6,008 | $137 |
| Return visit (30+ min) | 63 | $4,836 | $70 |
| Exam of ear using a microscope | 214 | $4,370 | $19 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 18 | $3,007 | $158 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 82 | $2,771 | $34 |
| Removal of impacted ear wax | 77 | $2,766 | $30 |
| Short return visit | 72 | $2,600 | $26 |
| Repositioning exercises of head for treatment of dizziness, each day | 55 | $2,051 | $29 |
| Placement of scalp electrodes for assessment and recording of responses from several areas of the nerve-brain hearing system | 17 | $1,551 | $91 |
| Evaluation and testing for balance with recording | 17 | $1,207 | $71 |
| Comprehensive hearing and speech recognition test | 28 | $668 | $24 |
| Test to assess balance during warm and cool irrigation in both ears | 15 | $439 | $29 |
| Use of electrodes during balance testing | 17 | $68 | $4 |
2016: 17 services
| Short return visit (20+ min) | 460 | $27,624 | $47 |
| New patient visit (45+ min) | 104 | $11,774 | $113 |
| New patient visit (30+ min) | 161 | $11,013 | $68 |
| Return visit (30+ min) | 57 | $4,624 | $75 |
| Exam of ear using a microscope | 212 | $4,569 | $21 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 123 | $4,450 | $36 |
| Incision of fluid canal of inner ear with infusion of drugs | 11 | $3,928 | $145 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 15 | $3,226 | $161 |
| Removal of impacted ear wax | 81 | $3,131 | $33 |
| Placement of scalp electrodes for assessment and recording of responses from several areas of the nerve-brain hearing system | 23 | $2,295 | $100 |
| Repositioning exercises of head for treatment of dizziness, each day | 52 | $2,235 | $32 |
| Evaluation and testing for balance with recording | 22 | $1,617 | $74 |
| Short return visit | 44 | $1,484 | $28 |
| Test to assess electrical potentials generated in the inner ear as a result of sound stimulation | 12 | $622 | $52 |
| Test to assess balance during warm and cool irrigation in both ears | 21 | $611 | $29 |
| Comprehensive hearing and speech recognition test | 28 | $538 | $19 |
| Use of electrodes during balance testing | 22 | $92 | $4 |
2015: 20 services
| Short return visit (20+ min) | 435 | $27,888 | $47 |
| New patient visit (45+ min) | 97 | $11,095 | $114 |
| New patient visit (30+ min) | 128 | $8,965 | $70 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 163 | $6,125 | $37 |
| Incision of fluid canal of inner ear with infusion of drugs | 15 | $6,004 | $143 |
| Return visit (30+ min) | 53 | $4,473 | $76 |
| Exam of ear using a microscope | 202 | $4,414 | $21 |
| Placement of scalp electrodes for assessment and recording of responses from several areas of the nerve-brain hearing system | 33 | $3,284 | $100 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 18 | $2,910 | $162 |
| Repositioning exercises of head for treatment of dizziness, each day | 61 | $2,555 | $32 |
| Evaluation and testing for balance with recording | 34 | $2,486 | $73 |
| Simple removal of skin debris and drainage of mastoid cavity | 15 | $1,614 | $95 |
| Assessment and recording of balance system during irrigation of both ears | 34 | $1,541 | $11 |
| Comprehensive hearing and speech recognition test | 70 | $1,503 | $21 |
| Removal of impacted ear wax | 28 | $1,079 | $36 |
| Short return visit | 20 | $717 | $29 |
| Test to assess electrical potentials generated in the inner ear as a result of sound stimulation | 11 | $592 | $54 |
| Test for ability to detect and repeat spoken words with speech recognition | 11 | $297 | $25 |
| Test for hearing various pitches using earphone | 11 | $272 | $21 |
| Use of electrodes during balance testing | 18 | $87 | $5 |
2014: 11 services
| Short return visit (20+ min) | 208 | $13,549 | $54 |
| New patient visit (45+ min) | 47 | $5,772 | $123 |
| Return visit (30+ min) | 54 | $4,742 | $79 |
| Exam of ear using a microscope | 142 | $3,772 | $22 |
| New patient visit (30+ min) | 44 | $3,287 | $75 |
| Removal of impacted ear wax | 78 | $2,780 | $36 |
| Comprehensive hearing and speech recognition test | 67 | $2,024 | $28 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 41 | $1,598 | $39 |
| Repositioning exercises of head for treatment of dizziness, each day | 33 | $1,521 | $33 |
| Test for ability to detect and repeat spoken words with speech recognition | 13 | $395 | $26 |
| Test for hearing various pitches using earphone | 13 | $333 | $22 |
Medicaid work
$9,038 in 2024
Medicaid paid $9,038 for 635 billed services this clinician did in 2024, up to 52 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Binocular microscopy | 377 | $3,422 |
| Comprehensive audiometry threshold evaluation and speech recognition | 118 | $2,046 |
| Return visit (30+ min) | 54 | $1,410 |
| New patient visit (60+ min) | 15 | $1,135 |
| New patient visit (45+ min) | 14 | $499 |
| Short return visit (20+ min) | 13 | $218 |
| Long return visit (40+ min) | 14 | $212 |
| Tympanometry and reflex threshold measurements | 30 | $96 |
| 2024 | 635 | 8 | 52 | $9,038 |
| 2023 | 873 | 4 | 51 | $10,466 |
| 2022 | 1,064 | 6 | 60 | $11,638 |
| 2021 | 1,693 | 12 | 89 | $19,039 |
| 2020 | 1,132 | 10 | 71 | $11,480 |
| 2019 | 669 | 4 | 40 | $5,570 |
| 2018 | 437 | 2 | 36 | $2,438 |
See the largest Medicaid services in earlier years
2023
| Binocular microscopy | 506 | $3,426 |
| Return visit (30+ min) | 120 | $2,857 |
| Comprehensive audiometry threshold evaluation and speech recognition | 165 | $2,310 |
| Short return visit (20+ min) | 82 | $1,872 |
2022
| Binocular microscopy | 559 | $2,900 |
| Short return visit (20+ min) | 169 | $2,533 |
| Comprehensive audiometry threshold evaluation and speech recognition | 200 | $2,476 |
| Return visit (30+ min) | 96 | $2,419 |
| New patient visit (45+ min) | 28 | $1,038 |
| New patient visit (30+ min) | 12 | $272 |
2021
| Short return visit (20+ min) | 274 | $4,791 |
| Return visit (30+ min) | 120 | $4,122 |
| Binocular microscopy | 797 | $3,867 |
| Comprehensive audiometry threshold evaluation and speech recognition | 254 | $3,067 |
| Graft; derma-fat-fascia | 30 | $1,704 |
| New patient visit (45+ min) | 67 | $1,187 |
| Tympanometry and reflex threshold measurements | 53 | $187 |
| New patient visit (30+ min) | 12 | $59 |
| AUDIOMETRY AIR & BONE | 12 | $56 |
| Reconstruction of external auditory canal | 14 | $0 |
| Microsurgical techniques, requiring use of operating microscope (List separately in addition to code for primary procedure) | 31 | $0 |
| Needle electromyography; cranial nerve supplied muscle(s), unilateral | 29 | $0 |
2020
| Short return visit (20+ min) | 193 | $3,887 |
| Binocular microscopy | 599 | $2,901 |
| Comprehensive audiometry threshold evaluation and speech recognition | 169 | $2,061 |
| Graft; derma-fat-fascia | 25 | $1,135 |
| New patient visit (45+ min) | 27 | $784 |
| New patient visit (30+ min) | 14 | $380 |
| Tympanometry and reflex threshold measurements | 31 | $153 |
| Return visit (30+ min) | 12 | $119 |
| Needle electromyography; cranial nerve supplied muscle(s), unilateral | 12 | $60 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 50 | $0 |
2019
| Binocular microscopy | 451 | $2,289 |
| Short return visit (20+ min) | 110 | $2,123 |
| Comprehensive audiometry threshold evaluation and speech recognition | 76 | $1,022 |
| Tympanometry and reflex threshold measurements | 32 | $137 |
2018
| Binocular microscopy | 405 | $1,947 |
| Short return visit (20+ min) | 32 | $491 |
Drugs they prescribed that Part D paid
$12,343
Pharmacies billed $12,343 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 9% of their Part D prescriptions (49 of 571) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
549 generic and 22 brand-name prescriptions · $12,343 in drug cost · 87 antibiotic prescriptions to 72 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciprofloxacin-Dexamethasone | 31 | $3,516 | $113 |
| Neomycin-Polymyxin-Hc | 63 | $3,182 | $51 |
| Ofloxacin | 49 | $1,512 | $31 |
| Triamterene-Hydrochlorothiazid | 41 | $771 | $19 |
| Propranolol Hcl Er | 13 | $386 | $30 |
See all 15 drugs
| Ciprofloxacin-Dexamethasone | 31 | $3,516 | $113 |
| Neomycin-Polymyxin-Hc | 63 | $3,182 | $51 |
| Ofloxacin | 49 | $1,512 | $31 |
| Triamterene-Hydrochlorothiazid | 41 | $771 | $19 |
| Propranolol Hcl Er | 13 | $386 | $30 |
| Ibuprofen | 53 | $222 | $4 |
| Fluticasone Propionate | 17 | $217 | $13 |
| Triamcinolone Acetonide | 46 | $151 | $3 |
| Hydrocodone-Acetaminophen | 44 | $151 | $3 |
| Cephalexin | 31 | $133 | $4 |
| Ciprofloxacin | 16 | $121 | $8 |
| Clindamycin | 19 | $105 | $6 |
| Prednisone | 28 | $104 | $4 |
| Meclizine | 17 | $68 | $4 |
| Methylprednisolone | 14 | $64 | $5 |
Year by year
| 2024 | 571 | 185 | 9% (49) | 4% | $12,343 |
| 2023 | 597 | 202 | 8% (45) | 8% | $23,327 |
| 2022 | 492 | 162 | 9% (43) | 5% | $16,845 |
| 2021 | 509 | 149 | 10% (53) | 4% | $13,402 |
| 2020 | 353 | 130 | 11% (37) | 6% | $10,779 |
| 2019 | 379 | 120 | 8% (31) | 8% | $15,409 |
| 2018 | 482 | 165 | 11% (53) | 12% | $15,388 |
| 2017 | 664 | 224 | 3% (17) | 5% | $12,725 |
| 2016 | 684 | 222 | 4% (25) | 8% | $15,091 |
| 2015 | 576 | 180 | None | 10% | $16,680 |
| 2014 | 279 | 138 | 9% (26) | 19% | $10,921 |
| 2013 | 112 | 52 | 25% (28) | 32% | $5,864 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Ciprofloxacin-Dexamethasone | 50 | $7,860 | $157 |
| Neomycin-Polymyxin-Hc | 98 | $5,649 | $58 |
| Ofloxacin | 40 | $1,872 | $47 |
| Triamterene-Hydrochlorothiazid | 43 | $969 | $23 |
| Fluticasone Propionate | 12 | $299 | $25 |
| Ciprofloxacin | 28 | $251 | $9 |
| Cephalexin | 34 | $204 | $6 |
| Ibuprofen | 46 | $153 | $3 |
| Triamcinolone Acetonide | 53 | $150 | $3 |
| Ondansetron Odt | 12 | $133 | $11 |
| Hydrocodone-Acetaminophen | 36 | $122 | $3 |
| Prednisone | 24 | $90 | $4 |
| Clindamycin | 11 | $71 | $6 |
| Diazepam | 11 | $44 | $4 |
2022: 11 drugs
| Neomycin-Polymyxin-Hc | 80 | $5,045 | $63 |
| Ciprofloxacin-Dexamethasone | 22 | $3,545 | $161 |
| Ofloxacin | 51 | $2,568 | $50 |
| Triamterene-Hydrochlorothiazid | 35 | $526 | $15 |
| Fluticasone Propionate | 29 | $514 | $18 |
| Cephalexin | 27 | $191 | $7 |
| Ibuprofen | 41 | $166 | $4 |
| Ciprofloxacin | 17 | $141 | $8 |
| Hydrocodone-Acetaminophen | 38 | $140 | $4 |
| Amoxicillin-Clavulanate Potass | 11 | $91 | $8 |
| Triamcinolone Acetonide | 32 | $78 | $2 |
2021: 14 drugs
| Neomycin-Polymyxin-Hc | 70 | $4,142 | $59 |
| Ofloxacin | 54 | $2,275 | $42 |
| Ciprofloxacin-Dexamethasone | 11 | $2,032 | $185 |
| Fluocinolone Acetonide Oil | 20 | $1,665 | $83 |
| Neomycin-Polymyxin-Hydrocort | 12 | $782 | $65 |
| Triamterene-Hydrochlorothiazid | 35 | $450 | $13 |
| Ibuprofen | 58 | $237 | $4 |
| Hydrocodone-Acetaminophen | 44 | $188 | $4 |
| Cephalexin | 34 | $168 | $5 |
| Amoxicillin-Clavulanate Potass | 13 | $154 | $12 |
| Triamcinolone Acetonide | 45 | $134 | $3 |
| Methylprednisolone | 14 | $110 | $8 |
| Ciprofloxacin | 11 | $96 | $9 |
| Prednisone | 17 | $70 | $4 |
2020: 9 drugs
| Ciprodex | 13 | $3,302 | $254 |
| Ofloxacin | 81 | $2,922 | $36 |
| Fluticasone Propionate | 11 | $234 | $21 |
| Triamterene-Hydrochlorothiazid | 12 | $189 | $16 |
| Cephalexin | 24 | $117 | $5 |
| Triamcinolone Acetonide | 31 | $106 | $3 |
| Hydrocodone-Acetaminophen | 33 | $102 | $3 |
| Ibuprofen | 29 | $95 | $3 |
| Prednisone | 16 | $86 | $5 |
2019: 12 drugs
| Ofloxacin | 77 | $5,742 | $75 |
| Ciprodex | 22 | $5,311 | $241 |
| Triamterene-Hydrochlorothiazid | 25 | $403 | $16 |
| Fluticasone Propionate | 26 | $257 | $10 |
| Methylprednisolone | 13 | $171 | $13 |
| Hydrocodone-Acetaminophen | 28 | $142 | $5 |
| Cephalexin | 29 | $135 | $5 |
| Triamcinolone Acetonide | 27 | $112 | $4 |
| Ibuprofen | 22 | $101 | $5 |
| Prednisone | 17 | $89 | $5 |
| Clindamycin | 11 | $59 | $5 |
| Diazepam | 12 | $20 | $2 |
2018: 12 drugs
| Ciprodex | 24 | $5,364 | $224 |
| Ofloxacin | 49 | $4,206 | $86 |
| Triamterene-Hydrochlorothiazid | 57 | $1,125 | $20 |
| Ciprofloxacin | 64 | $724 | $11 |
| Hydrocodone-Acetaminophen | 40 | $391 | $10 |
| Fluticasone Propionate | 13 | $268 | $21 |
| Cephalexin | 38 | $201 | $5 |
| Triamcinolone Acetonide | 34 | $131 | $4 |
| Methylprednisolone | 11 | $123 | $11 |
| Acetaminophen-Codeine | 11 | $59 | $5 |
| Prednisone | 12 | $56 | $5 |
| Montelukast | 11 | $23 | $2 |
2017: 14 drugs
| Ciprodex | 12 | $2,580 | $215 |
| Triamterene-Hydrochlorothiazid | 142 | $2,259 | $16 |
| Ciprofloxacin | 70 | $1,114 | $16 |
| Fluticasone Propionate | 33 | $523 | $16 |
| Spironolactone | 30 | $405 | $14 |
| Triamcinolone Acetonide | 63 | $276 | $4 |
| Methylprednisolone | 19 | $264 | $14 |
| Diazepam | 45 | $261 | $6 |
| Prednisone | 40 | $189 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $174 | $15 |
| Hydrocodone-Acetaminophen | 17 | $128 | $8 |
| Meclizine | 20 | $116 | $6 |
| Famotidine | 21 | $65 | $3 |
| Cephalexin | 15 | $65 | $4 |
2016: 15 drugs
| Ciprodex | 27 | $5,061 | $187 |
| Triamterene-Hydrochlorothiazid | 140 | $1,774 | $13 |
| Ciprofloxacin | 72 | $1,154 | $16 |
| Clonazepam | 13 | $566 | $44 |
| Methylprednisolone | 31 | $455 | $15 |
| Spironolactone | 35 | $426 | $12 |
| Fluticasone Propionate | 23 | $352 | $15 |
| Hydrocodone-Acetaminophen | 19 | $287 | $15 |
| Diazepam | 56 | $272 | $5 |
| Triamcinolone Acetonide | 39 | $199 | $5 |
| Prednisone | 34 | $168 | $5 |
| Meclizine | 23 | $122 | $5 |
| Famotidine | 19 | $107 | $6 |
| Cephalexin | 22 | $94 | $4 |
| Ibuprofen | 13 | $38 | $3 |
2015: 15 drugs
| Ciprodex | 26 | $4,518 | $174 |
| Triamterene-Hydrochlorothiazid | 108 | $1,431 | $13 |
| Methylprednisolone | 25 | $497 | $20 |
| Diazepam | 87 | $405 | $5 |
| Ofloxacin | 11 | $366 | $33 |
| Spironolactone | 29 | $277 | $10 |
| Amitriptyline | 19 | $213 | $11 |
| Prednisone | 31 | $183 | $6 |
| Fluticasone Propionate | 16 | $173 | $11 |
| Meclizine | 11 | $140 | $13 |
| Triamcinolone Acetonide | 28 | $119 | $4 |
| Hydrochlorothiazide | 15 | $119 | $8 |
| Clonazepam | 14 | $100 | $7 |
| Alprazolam | 13 | $91 | $7 |
| Amoxicillin | 11 | $57 | $5 |
2014: 9 drugs
| Ciprodex | 34 | $5,355 | $157 |
| Triamterene-Hydrochlorothiazid | 20 | $368 | $18 |
| Methylprednisolone | 14 | $289 | $21 |
| Prednisone | 19 | $211 | $11 |
| Cephalexin | 22 | $113 | $5 |
| Hydrocodone-Acetaminophen | 14 | $101 | $7 |
| Diazepam | 25 | $95 | $4 |
| Triamcinolone Acetonide | 14 | $60 | $4 |
| Acetaminophen-Codeine | 11 | $51 | $5 |
2013: 4 drugs
| Ciprodex | 34 | $5,099 | $150 |
| Cephalexin | 30 | $153 | $5 |
| Hydrocodone-Acetaminophen | 14 | $97 | $7 |
| Acetaminophen-Codeine | 12 | $62 | $5 |
Money from drug and device companies
$352 in 2025
| 2025 | 2 | 4 | None | $352 |
| 2024 | 6 | 11 | None | $1,268 |
| 2023 | 1 | 1 | None | $5,000 |
| 2022 | 2 | 5 | None | $86 |
| 2021 | 1 | 1 | None | $13 |
| 2020 | 1 | 1 | None | $118 |
| 2019 | 3 | 4 | None | $241 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Cochlear Americas | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $333 | 3 payments
|
| Med-El | Mi1250 Synchrony 2 Flexsoft | $19 | 1 payment
|
See all 4 published payments
| Cochlear Americas | Meals · 2025-11-20 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $150 |
| Cochlear Americas | Meals · 2025-11-20 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $160 |
| Med-El | Meals · 2025-08-25 | Mi1250 Synchrony 2 Flexsoft | $19 |
| Cochlear Americas | Meals · 2025-04-21 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,268
| Oticon Medical | Ponto Bone Anchored Hearing System | $780 | 2 payments
|
| Inspire Medical Systems | Inspire | $200 | 2 payments
|
| Genzyme | Dupixent | $120 | 1 payment
|
| Integra LifeSciences | Integra | $117 | 1 payment
|
| Med-El | Mi1250 Synchrony 2 Flexsoft | $26 | 1 payment
|
| Cochlear Americas | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $24 | 1 payment
|
2023: $5,000
| Med-El | Mi1250 Synchrony 2 Flexsoft | $5,000 | 1 payment
|
2022: $86
| Advanced Bionics | Hires Ultra Ci Hifocus Ms Electrode | $55 | 4 payments
|
| Cochlear Americas | Cochlear | $32 | 1 payment
|
2021: $13
| Advanced Bionics | Hires Ultra Ci Hifocus Ms Electrode | $13 | 1 payment
|
2020: $118
| Regeneron Healthcare Solutions | Dupixent | $118 | 1 payment
|
2019: $241
| Intersect ENT | Propel | $91 | 1 payment
|
| DePuy Synthes Sales | Trumatch | $88 | 1 payment
|
| Cochlear Americas | Nucleus | $62 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Hill Dermaceuticals, Inc. · Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis) · 2021 | This clinician | $26,073 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 68.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1376703454
- Licence
- CA A150679, IL 125053418, IN 01073373A, MI 4301099963California A150679: Current · expires 2027-07-31Illinois 125053418: Expired
- Trained
- University of Missouri, Columbia School of Medicine, 2007 · 19 years ago
- Group
- Sacramento Ear Nose and Throat Surgical and Medical Group Inc · Marshall Medical Center
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- IN 201230760
- Taxonomy
- Federal specialty code 207YX0901X (207YX0901X); Otolaryngology (207Y00000X)
- Mailing address
- 1111 Exposition Blvd Bldg 700, Sacramento, CA, 95815
- NPI first listed
- 2008-06-12
- NPI last updated
- 2020-05-07
- NPI record certified
- 2020-05-07
This is when the NPI record was last certified, not a medical board exam.